top of page
AI for Neuromuscular & MSK Care
We optimize the assessment, monitoring, and treatment
of neuromuscular and musculoskeletal disorders through AI-based digital biomarkers.
CORE VALUE
We transform the diagnostic pathway for neuromuscular and musculoskeletal disorders.
Our AI-driven digital biomarkers enable diagnostic support, severity assessment,
and disease progression monitoring.
CNS
Digital Biomarker
PNS
Digital Biomarker
AI Digital Biomarker
Stroke · Parkinson’s · ALS ·
SMA Severity Assessment
Sarcopenia · Myasthenia gravis (MG) Diagnostic Support
Quantitative Neuromuscular assessment
VALUE POINT
Faster, Broader, More reproducible.
Powered by AI-based digital biomarkers.
Improved operational efficiency
By reducing labor-intensive measurement procedures to an approximately 3-minute evaluation process, we enhance clinical and operational efficiency.
Expanded patient accessibility
We enable simple, non-invasive assessment for patients with limited mobility and for populations where conventional protocols are difficult to apply.
Enhanced reproducibility and standardization
By minimizing examiner-dependent variability and patient condition-related fluctuations, we support consistent interpretation through standardized quantitative metrics.
OUR SOLUTION
Expanding the application of AI digital biomarkers
across healthcare and wellness.
Our Partners
Through partnerships with medical and healthcare leaders,
we validate and scale our solutions.
bottom of page